CLINICAL REVIEW OF HOW GLUCAGON-LIKE PEPTIDE-1 AGONIST OBESITY MEDICATIONS DECREASE SEXUAL DESIRE, AND A BIOPSYCHOSOCIAL MODEL FOR WHY WE DON’T ‘SEE’ IT

Descargar Publicación
Glucagon Like Peptide-1 Receptor Agonists for Sarcopenia and Muscle Wasting Disorders: A Systematic Review of Efficacy and Mechanisms Mechanism-guided pharmacotherapy for cardiometabolic multimorbidity: from pathophysiology to phenotype-prioritized treatment